The headline results at 80 weeks were: 12 mg dose: average weight loss of 28.3% (approximately 70.3 lbs / 31.9 kg) 9 mg dose: average weight loss of 25.9% (approximately 64.4 lbs / 29.2 kg) 4 mg dose: average weight loss of 19.0% (approximately 47.2 lbs / 21.4 kg) Placebo: average weight loss of just 2.2% Perhaps most striking was the proportion of patients hitting bariatric-surgery-level outcomes: at the highest dose, 45.3% of participants lost 30% or more of their body weight , and 65.3% reduced their BMI to below 30 kg/m meaning they were no longer classified as living with obesity by the end of the trial
No Validated Epithalon Age-Reversal Test Commercial testing before and after Epithalon exposure cannot establish rejuvenation unless the test is validated, the change exceeds normal variation and a controlled comparator is included
Verify tesamorelin free-base mass near 5,135.9 Da
Call us.
Understanding the difference between a mild skin reaction, hives, and a more serious allergic response can help you recognise when symptoms are likely to improve on their own and when medical advice may be needed
Safety Considerations, Drug Interactions, and Who Should Evaluate Methylene Blue Common side effects include blue discoloration of urine and skin, nausea, and headacheusually mild and reversible